It has been reported that EGFR acts as the upstream signaling molecule of the AKT pathway in the suppression of inhibitor of differentiation 3 (ID3)-stimulated IL-8 expression in glioma stem-like cells [37]. The gene discussed is AKT1; the disease is glioma.